MiR-20a-5p regulates gemcitabine chemosensitivity by targeting RRM2 in pancreatic cancer cells and serves as a predictor for gemcitabine-based chemotherapy

Lignende værker

• miR-25 expression is upregulated in pancreatic ductal adenocarcinoma and promotes cell proliferation by targeting ABI2
  af: Lu, Huimin, et al.
  Udgivet: (2020)
• The serum miR‐21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR‐21 expression confers chemoresistance by targeting FasL
  af: Wang, Peng, et al.
  Udgivet: (2012)
• miR-29b, miR-205 and miR-221 Enhance Chemosensitivity to Gemcitabine in HuH28 Human Cholangiocarcinoma Cells
  af: Okamoto, Kinya, et al.
  Udgivet: (2013)
• miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EMT axis
  af: Yang, Rui-Meng, et al.
  Udgivet: (2017)
• Metformin Increases the Chemosensitivity of Pancreatic Cancer Cells to Gemcitabine by Reversing EMT Through Regulation DNA Methylation of miR-663
  af: Gu Y, et al.
  Udgivet: (2020-10-01)